Recruiting PHASE1, PHASE2 Bell Palsy

Compares treatment options for Bell Palsy

Official title Efficacy of Prednisolone Versus Cerebrolysin in the Treatment of Bell's Palsy

ClinicalTrials.gov ID: NCT05821075

What this study is testing

What is Prednisolone?

Prednisolone is an investigational medicine, given as an once-daily pill taken by mouth, being studied as a potential treatment for bell palsy.

Plain-language explanation of the investigational treatment - it is being studied and is not an approved or proven therapy. The study team can confirm the details.

What it's testing
Bell's palsy, a peripheral facial nerve paresis, is the most common disorder of the facial nerve and one of the most common mononeuropathies. Many patients with Bell's palsy will develop some complications such as synkinesis, crocodile tears and 'sweating' of the ear while eating Commonly used medications to treat Bell's palsy is Corticosteroids Cerebrolysin stimulates the regeneration of the nervous tissue with protective action we aim to study the efficacy of cerebrolycin in Bell's palsy
  • Phase 2: a mid-size study of how well it works

A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.

Who can take part

Ages 18 to 60

You may be able to join if

  • unilateral acute facial palsy of no identifiable cause

You likely can't join if

  • Recurrent facial Bell's palsy
  • Pregnancy
  • Diabetes
  • Epilepsy
  • Severe hypertension,
  • Renal or hepatic disease,
See the full eligibility criteria
Who can join
  • unilateral acute facial palsy of no identifiable cause
What rules you out
  • Recurrent facial Bell's palsy
  • Pregnancy
  • Diabetes
  • Epilepsy
  • Severe hypertension,
  • Renal or hepatic disease,
  • Gastric or duodenal ulcer
  • presence of acute otitis media or ipsilateral chronic otitis
  • Recent head injury,
  • psychiatric disease
  • If there is any contraindications for corticosteroids

The study team makes the final eligibility decision.

Where it's taking place

  • Giza, Egypt

Questions & answers

Do participants get paid in this trial?

This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.

Is it free to join, and do I need insurance?

Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.

How long does this study last?

The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.

Who can join this trial?

This study is enrolling all sexes, 18 years to 60 years. The study team makes the final eligibility decision.

Where is this trial taking place?

Study sites include Giza, Egypt. Enter your location above to see the nearest site and check your eligibility.

Explore other conditions

BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.